Literature DB >> 3616519

Prognostic scale for chronic schizophrenia.

W S Fenton, T H McGlashan.   

Abstract

Although prognostic scales are available for schizophrenia, these focus on acute or subacute populations where premorbid functioning and established chronicity are the best predictors of outcome. Their usefulness in chronic schizophrenia is limited. The authors describe a simple and reliable 5-item, 12-point prognostic scale for chronic schizophrenia independent of chronicity. It measures prognosis as the product of a dynamic interplay between the highest level of adaptive occupational and social functioning ever achieved by the individual and the "invasiveness" of the Axis I disorder as manifest by genetic loading (family history of schizophrenia), erosion of reality testing (psychotic assaultiveness), and preservation of affect in psychopathology (depressed mood). Among chronic schizophrenic patients in the Chestnut Lodge Followup Study (n = 163), the prognostic score (based on history and admission clinical picture) allowed strong probabilistic statements to be made about long-term outcome. Tables present the conditional probability or risk of specific outcomes in the domains of institutionalization, work functioning, social relations, and global outcome for patients at varying levels along the prognostic spectrum. Close examination of these predictor-outcome relationships suggests that prognosis in chronic schizophrenia may be thought of as the variability (as opposed to fixedness) remaining in the individual's future life course, and poor outcome can be predicted with greater sensitivity than good outcome.

Entities:  

Mesh:

Year:  1987        PMID: 3616519     DOI: 10.1093/schbul/13.2.277

Source DB:  PubMed          Journal:  Schizophr Bull        ISSN: 0586-7614            Impact factor:   9.306


  6 in total

1.  Identifying unmet therapeutic domains in schizophrenia patients: the early contributions of Wayne Fenton from Chestnut Lodge.

Authors:  Thomas H McGlashan; William T Carpenter
Journal:  Schizophr Bull       Date:  2007-07-18       Impact factor: 9.306

2.  Facts and meaning in psychiatry. An anthropological approach to the lifeworld of schizophrenics.

Authors:  E E Corin
Journal:  Cult Med Psychiatry       Date:  1990-06

Review 3.  Does olanzapine warrant clinical pharmacokinetic monitoring in schizophrenia?

Authors:  Erin Schwenger; Jane Dumontet; Mary H H Ensom
Journal:  Clin Pharmacokinet       Date:  2011-07       Impact factor: 6.447

4.  Prediction of functional outcome in individuals at clinical high risk for psychosis.

Authors:  Ricardo E Carrión; Danielle McLaughlin; Terry E Goldberg; Andrea M Auther; Ruth H Olsen; Doreen M Olvet; Christoph U Correll; Barbara A Cornblatt
Journal:  JAMA Psychiatry       Date:  2013-11       Impact factor: 21.596

5.  To tell or not to tell the diagnosis of schizophrenia.

Authors:  J M Atkinson
Journal:  J Med Ethics       Date:  1989-03       Impact factor: 2.903

6.  Cortical folding and the potential for prognostic neuroimaging in schizophrenia.

Authors:  Shuixia Guo; Sarina Iwabuchi; Vijender Balain; Jianfeng Feng; Peter Liddle; Lena Palaniyappan
Journal:  Br J Psychiatry       Date:  2015-07-23       Impact factor: 9.319

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.